S

Stryker

Manufactures orthopedic and surgical medical devices

Foot & Ankle Sales Associate

Full-TimePosted on 10/21/2026
$65k+ Commission + Bonuses
Mid
Bachelor's, Associate's
Atlanta, GA, USA
In PersonTerritory primarily covers Greater Atlanta, with travel throughout Georgia and north to Chattanooga, Tennessee; travel is 60%.
Sales & Account ManagementField Sales
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree, or an associate's degree or medical certification (such as CST, PT, or CPT) plus at least 2 years of professional and/or related experience, or a high school diploma plus at least 4 years of professional and/or related experience, or 4 or more years of active-duty military service.
  • Travel throughout the assigned region is required, including Georgia and areas as far north as Chattanooga, Tennessee.
  • Sales and field employees who require customer-account access may be required to obtain COVID-19 vaccination, depending on customer requirements.
Responsibilities
  • Partner with area Sales Representatives to learn the medical device industry and Foot & Ankle business, contribute to assigned-territory growth, support all aspects of the sales call pattern, cover cases, market and promote products in assigned accounts, build sets, manage inventory, and begin converting customers as knowledge and experience grow.
  • Attend surgeries involving Foot & Ankle products to ensure products are available and instruct surgeons on product use and functionality.
  • Educate doctors, nurses, and appropriate staff on proper use and maintenance of products, product functionality and updates, portfolio changes, and educational programs.
  • Work with sales teams to contact customers, identify sales opportunities, provide customer service, and develop customer relationships.
  • Identify new prospects' needs with the assigned Sales Representative and develop appropriate responses.
  • After product training, tailor promotional messages to customers, advise on product selection, answer product-functionality questions, and distinguish products from competitors.
  • Perform field calls for assigned accounts and territory.
  • Assist with implementing sales plans and marketing strategies, and partner with Sales Representatives and the organization to meet business targets and quotas.
  • Serve as the primary backup contact for Sales Representatives, learn applicable regulatory compliance requirements, and follow those guidelines.
  • Assist in resolving account problems or questions.
  • Partner with Sales Representatives on inventory management and maintaining appropriate inventory levels and sets to meet customer needs.
  • Assist Sales Representatives with obtaining and processing customer purchase orders for invoicing, and maintain training in sales skills and products.
  • Market the product line based on product functionality, features, and competitive differentiation, and stay current on industry, customer, and competitor trends.
  • Attend sales meetings and professional association meetings outside regular business hours.
  • Follow compliance and AdvaMed principles, protect privacy, confidentiality, and organizational assets, act ethically, report non-compliance, and comply with applicable laws, regulations, accreditation and licensure requirements, and company policies and procedures.
Desired Qualifications
  • One year of B2B sales or clinical experience.

About the company

Stryker makes medical devices for hospitals, surgical centers and emergency responders, spanning joint implants, surgical instruments and patient transport equipment. Its Mako platform assists surgeons with joint replacement, while its neurotechnology products support brain and spine procedures and stroke treatment. Clinicians use its equipment during surgery and emergency care, and the company earns money by selling implants, disposable products and capital equipment through direct sales teams and distributors. The business also supplies training and technical support for healthcare providers using its devices. Stryker was founded in 1941 and is headquartered in Portage, Michigan.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand supports growth: July 2026 Stryker results show organic sales rose 9%, with reported sales reaching $6.6 billion.
  • Service extends equipment sales: Stryker's ProCare contracts bundle preventive maintenance, repairs and original manufacturer parts.
  • Relocation is available for Worcester technicians: Stryker's live transport service opening also lists 12 paid holidays.

What critics are saying

  • Operational failures reach customers: March 2026 cyberattack disrupted Stryker's ordering, manufacturing and shipping.
  • Older implants retain legal exposure: Stryker's recall estimates include Rejuvenate, LFIT V40 and legacy Wright hip products.
  • Field service demands travel: Stryker's northern Minnesota opening lists 80% travel plus evening or weekend call.

What makes Stryker unique

  • Mako combines imaging and physical guidance: Stryker uses CT-based planning and haptic boundaries during hip replacement.
  • Discarded devices return to service: Stryker's Sustainability Solutions reprocesses medical equipment for hospitals across the U.S. and Canada.
  • Transport extends its technology outside hospitals: Stryker's Power-LOAD supports stretchers while loading and unloading ambulances.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Medical & prescription plans
  • Supplemental health benefits
  • Flexible Spending accounts
  • Employee Assistance Program
  • Short-term & long-term disability
  • Tuition reimbursement
  • 401(k) plan
  • Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 21st, 2026
P&G and Stryker: two dividend stocks to hold for decades

Procter & Gamble and Stryker are two dividend stocks suited to long-term holders, according to the article. Both sell products people need in any economy. P&G has raised its dividend for 70 consecutive years. In fiscal 2026, it posted net sales of about $87 billion, up 3%, and net earnings of $16.1 billion. It returned more than $15 billion to shareholders, including $10.2 billion in dividends. Organic sales and core earnings per share each grew just 1%. Stryker has raised its dividend for more than three decades. Second-quarter 2026 revenue rose 9.4% to $6.6 billion, and adjusted earnings per share climbed 17.9% to $3.69. Demand should gain from an ageing US population, though recalls, acquisition costs, and hospital spending pressures remain risks.

Yahoo Finance
Oct 14th, 2026
Stryker wins FDA clearance for Sonopet 3 ultrasonic bone and tissue removal platform

Stryker has received US Food and Drug Administration (FDA) 510(k) clearance for Sonopet 3, the latest version of its ultrasonic bone and soft tissue removal platform. The company announced the news on October 14, 2026. Stryker developed the platform with input from hundreds of surgeons. It offers more power, precision and versatility, along with two technologies: RISE, which connects the surgical workflow, and Pulse Control, which helps regulate the resection of hard and soft tissues. "They told us they wanted more power, improved ergonomics and enhanced integration," said Mitch Foley, vice president and general manager of Stryker's Neurosurgical business. The first clinical cases are expected to begin in October. A full commercial launch is planned for later this fall.

Yahoo Finance
Oct 12th, 2026
Stryker shares fall 20% in six months despite 9.2% organic growth and $25.84B revenue

Stryker (NYSE:SYK) shares have fallen 20% over the past six months to $277.82, while the S&P 500 gained 12.8%. The medical device maker develops orthopedic, surgical, neurotechnology, and patient care products that reach over 150 million patients a year. Organic revenue, which excludes acquisitions, divestitures, and currency swings, grew an average of 9.2% year-on-year over the past two years. That suggests Stryker can expand without costly acquisitions. Revenue over the past 12 months was $25.84 billion. Its scale gives it leverage with suppliers in a heavily regulated, competitive market. Free cash flow margin rose 6.5 percentage points over five years to 18.2% for the trailing 12 months. After the drop, the stock trades at 17.4× forward earnings.

Seeking Alpha
Oct 12th, 2026
Stryker to invest $400M in CMR Surgical, with option to buy the robotics maker outright

Stryker announced a $400 million (£300 million) preferred equity investment in CMR Surgical on Monday. The money will support innovation and global expansion of CMR's Versius surgical robotics portfolio. The deal also gives Stryker an exclusive option to acquire 100% of CMR Surgical.

PR Newswire
Oct 5th, 2026
Stryker launches Mako 4 SmartRobotics in India after 2.5M procedures globally

Stryker has launched Mako 4 SmartRobotics in India, introducing the fourth generation of its robotic-arm assisted technology for joint replacement procedures. The system combines patient-specific planning, robotic technology, and haptic guidance for total knee, partial knee, and total hip applications. Mako 4 uses 3D CT-based planning with AccuStop haptic technology to support surgeons in planning and executing procedures according to individual patient anatomy. The platform provides real-time intraoperative guidance for greater precision during joint replacement procedures. The global Mako platform has supported more than 2.5 million procedures across 47 countries. Aman Rishi, Stryker's vice president and general manager for India, said the launch aims to raise the standard of care and expand access for joint replacement patients nationwide.